Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Acer Therapeutics Inc. (ACER)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Jun-05-23Mar-31-23Mar-05-23Dec-31-22Dec-05-22Sep-30-22Jun-30-22
   10-Q8-K10-Q8-K10-K8-K10-Q10-Q
Revenues  2.4 2.6 0.0 3.83.5
            Revenue growth  572.5% 634.7% -100.0% 320.8%292.4%
Cost of goods sold  4.8 5.3 0.0 6.96.3
Gross profit  0.0 0.0 0.0 0.40.4
            Gross margin  -100.0% -99.0%   100.0%100.0%
Selling, general and administrative   [+]17.1 19.9 21.9 21.420.7
Research and development        2.7 
Other operating expenses  33.4 17.0 -1.3  -5.7
EBITDA   [+]    -23.4 -18.1 
            EBITDA margin  -1266.5% -1373.6%   -711.0%-336.9%
Depreciation and amortization      0.0 0.0 
EBIT   [+]-30.6 -36.3 -23.3 -18.1-11.9
            EBIT margin  -1264.9% -1374.2%   -710.0%-336.0%
Other income (expense), net   [+]14.4 6.3 -2.9 8.31.5
Pre-tax income  -22.5 -33.3 -26.2 -18.6-10.4
Income taxes  0.0 0.0 0.0 0.00.0
            Tax rate  0.0% 0.0% 0.0% 0.0%0.0%
Net income  -22.5 -33.3 -26.2 -18.6-10.4
            Net margin  -928.6% -1260.6%   -491.4%-293.4%
   
Basic EPS   [+]($1.16) ($2.10) ($1.91) ($1.24)($0.80)
Diluted EPS   [+]($1.16) ($1.91) ($1.71) ($1.19)($0.71)
   
Shares outstanding (basic)   [+]19.4 15.9 13.8 15.012.9
Shares outstanding (diluted)   [+]19.4 17.5 15.4 15.614.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy